Data for: Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK

Published: 26 April 2021| Version 1 | DOI: 10.17632/dnnpnkx57h.1
Contributors:
Emily Rickard,
Piotr Ozieranski

Description

This dataset draws on pharmaceutical company disclosures of payments made to patient organisations in 2012-2016. It contains the transparency variables that apply to our manuscript: Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK. It includes three tabs. 1) The availability of disclosures for each pharmaceutical company, 2) a list of all disclosed payments to patient organisations and their performance on our transparency indicators, 3) a list of excluded payments and the reasons for exclusion.

Files

Categories

Health Policy, Social Policy, Pharmaceutical

License